Table 1.
Residue | Modification | Relation with gene expression | Localization |
---|---|---|---|
Histone H3 | |||
K4 | me1 | Inactive or active [74] | Widespread[75]; Enhancers[74, 76] |
me2 | Active[77, 78] | TSS[75] | |
me3 | Active[75–80]; Inactive(Poised)[81, 82] | TSS[75, 76, 80] | |
R8 | Me | Inactive [83, 84] | |
K9 | Ac | Active[75, 77, 79, 80, 85–87] | TSS[75, 80, 85] |
me3 | Inactive[79, 82, 88, 89] | Heterochromatin [90] | |
S10 | P | Active[91, 92] | TSS [92] |
K14 | Ac | Active[75, 77, 85–87] | TSS[75, 85] |
K16 | Ac | Active[79] | |
R17 | me1/me2-asym | Active [93] | |
K18 | Ac | Active[87, 93] | |
K20 | me1 | Inactive [88] | |
K23 | Ac | Active[87, 93] | |
K27 | Ac | Active [74] | Enhancer [74] |
me3 | Inactive[79, 81, 82, 88, 89] | ||
K36 | me3 | Active[80, 82, 85]; Hallmark of elongation[79, 85] | Coding[80] |
K79 | me1 | Inactive[94] | TSS or Intergenic[94] |
me2 | Active[94] | Coding[80]; TSS[94] | |
me3 | Active[94] | TSS[94] | |
Histone H4 | |||
R3 | me2 (sym) | Inactive[83, 95, 96] | TSS[95] |
K5/K8/K12/K16 | Ac | Active[78] | Widespread[75] |
K20 | me3 | Inactive [82] |
Abbreviations: ac: acetylation; K: lysine residues; me: methylation, where me1, 2, 3 denotes mono-, di-, or trimethylation; P: phosphorylation; R: arginine residue; (a) sym: (a) symmetrical; TSS: Transcription Start Site